In this work, the preparation of a PEG@ multi-walled carbon nanotubes (MWCNTs) composite has shown a great potential effect in tumor therapy using graphite powder at room temperature. PEGylated MWCNTs were created and used as a carrier for targeting the antineoplastic drug Ixazomib to myeloma cancer cells (abnormal plasma cells). Ixazomib (MLN2238) was covalently encapsulated into functionalized carbon nanotubes modified with polyethylene glycol (PEG 600) to obtain MWCNTs-PEG-MLN2238. The Ixazomib@ MWCNTs-PEG composite shows promising results as an effective nanocarrier and using a small amount of MWCNTs-PEG-Ixazomib that has a low toxicity compared with that of Ixazomib alone. A multifunctional MWCNTs-PEG-Ixazomib composite is used to test biological effects on multiple myeloma cell lines RPMI 8226 using the MTT assay to enhance treatment efficiency. The cytotoxicity of free Ixazomib citrate (69% cell viability of RPMI8226 cells) was higher than that of MWCNTs-PEG-Ixazomib (91% cell viability) at the same maximum concentration of Ixazomib citrate (50 µg/ml). In this work, we performed a study of preparation of MWCNTs with an acceptable Ixazomib loading efficiency and determination of the drug systemic toxicity for the first time. In this study, the preparation of MWCNTs with acceptable Ixazomib loading efficiency and determination of the drug systemic toxicity was performed for the first time. The MTT assay results show decreasing the toxicity of Ixazomib after loading with the MWCNTs-PEG composite. The MWCNTs-PEG @ Ixazomib show promising results as an effective carrier of Ixazomib and lead to a decrease in the cost of using Ixazomib. Graphical Abstract
8 November 2024 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Background: Green Fourier transform infrared (FTIR) spectroscopy, using potassium bromide (KBr) disc technique, eliminates the consumption of hazardous chemicals. Spectrofluorimetry for drugs that have native fluorescence. Mean centering of ratio spectra (MCRS) analysing overlapped spectra without preliminary separation.Objective: Three simple, accurate, and sensitive methods have been developed and validated for the determination of canagliflozin (CANA); one is a stability-indicating method for CANA and metformin (MET) determination.Methods: Method A is FTIR using a KBr disc for CANA determination measuring alkyl halide C–F peak area centered on 1230/cm. Method B is spectrofluorimetry using Δ λ = 50 nm synchronous mode at a peak maximum of 291.8 nm for CANA determination using methanol as solvent. Method C is a stability-indicating MCRS method measuring the peak amplitude of CANA and MET at 306.2 and 246.6 nm, respectively, in their mixture with complete CANA oxidation degradation.Results: The linear ranges were: FTIR spectroscopy, 1.50–24.70 μg/mg CANA; spectrofluorimetry, 100.00–600.00 ng/mL CANA; and MCRS, 1.00–25.00 μg/mL CANA and 1–30 μg/mL MET.Conclusion: All results were statistically compared with a reported method: no significant difference was observed.Highlights: The proposed methods can be used efficiently for routine analysis in QC laboratories. A green FTIR method utilizes only one reagent, KBr. Spectrofluorimetry using a constant wavelength synchronous scan of CANA native fluorescence in nanogram concentrations overcomes conventional excitation/emission spectra drawbacks and proves that the solvent effect in the fluorescence intensity differs according to concentration used. Stability-indicating MCRS determines the studied drugs in bulk, pharmaceutical formulations, accelerated and long-term stability study samples.
A rapid, precise and selective RP-LC method was developed for the simultaneous determination of the well-known beta blocker, Timolol (TIM), along with some of the most commonly prescribed prostaglandin analogues, namely; Bimatoprost (BIM), Latanoprost (LAT) and Travoprost (TRV), in laboratory prepared mixtures and in their combined pharmaceutical formulations. The chromatographic separation was carried out using gradient elution mode with a mobile phase consisting of 25 mM phosphate buffer (pH 3 ± 0.1), acetonitrile and methanol at a flow rate of 1 mL/min on a stationary phase composed of Thermo Hypersil BDS C18 (4.6×250 mm, 5 μm) column. UV detection was carried out at 295 nm and 210 nm wavelength gradient at 25°C. The method was validated according to ICH guidelines. Linearity, accuracy and precision results were satisfactory over the concentration ranges of 10.00-600.00 μg/ml for TIM and 1.00-60.00 μg/ml for BIM, LAT and TRV. The correlation coefficients (r2 values) were 0.9965 for TIM, 0.99995 for BIM, 0.99998 for LAT and 0.99996 for TRV. The method was successfully applied for the determination of TIM in its synthetic mixture and co-formulated eye drops with each of the three prostaglandin analogues BIM, LAT or TRV. The developed method is specific and accurate for the quality control and routine analysis of the cited drugs in their pharmaceutical preparations. This method is considered global and can be applied to all prostaglandin analog combinations with TIM.
12 October 2021 in Journal of the Iranian Chemical Society
A simple, rapid and fully-validated liquid chromatographic method (RP HPLC) with fluorescence detection was developed for the analysis of rhein (as the main metabolite of diacerein) in human plasma. The separation was performed using an ODS C18 column with mobile phase acetonitrile: methanol: phosphate buffer pH 6.8 and the flow rate was1.0 mL/min. The fluoremetric detection was performed at 2 excitation wavelengths ʎex= 440 nm & 338 nm and one emission wavelength at ʎ em = 520 nm . The developed method was validated according to Food and Drug Adminstration (FDA) guideline for bioanalytical method validation. The pharmacokinetic parameters of the test and reference were determined and the analysis of variance (ANOVA) between parameters of the two brands were calculated. The relative bioavailability was found to be 89%. This method was successfully applied to the routine bioequivalence analysis of diacerein in plasma.